Decreasing Blood Transfusions in Premature Infants Through Quality Improvement

Kwai Tei C Chan Poon1, Lusia Li1, Rick Pittman1

  • 1Department of Pediatrics, Division of Neonatology, Duke University Hospital, Durham, North Carolina.

Pediatrics
|July 17, 2024
PubMed

Insights

This study reduced packed red blood cell transfusions (pRBCT) in preterm infants (26-34 weeks gestation) by 46.6%. Quality improvement strategies successfully decreased transfusions without impacting mortality or necrotizing enterocolitis.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Quality Improvement Science

Background:

  • Packed red blood cell transfusions (pRBCT) are common in preterm infants and associated with morbidity.
  • Preterm infants between 26 and 34 weeks' gestational age may receive preventable pRBCT.
  • Reducing pRBCT in this population is a key quality improvement goal.

Purpose of the Study:

  • To decrease pRBCT in preterm infants (26-34 weeks gestation) by 20% using quality improvement methods.
  • To implement evidence-based transfusion guidelines and supportive therapies.
  • To monitor transfusion rates and related process measures.

Main Methods:

  • A quality improvement project was conducted in a Neonatal Intensive Care Unit (NICU) from July 2018 to February 2023.
  • Interventions included evidence-based transfusion thresholds, erythropoiesis support, and reduced laboratory draw volumes.
  • Statistical process control charts monitored pRBCT rates, erythropoietin use, and laboratory panel utilization.

Main Results:

  • pRBCT decreased by 46.6%, from 23.8 to 12.7 transfusions per 1000 patient days.
  • Erythropoietin use and capillary panel testing increased; basic metabolic panel use decreased.
  • No significant changes were observed in mortality or necrotizing enterocolitis rates.
  • The observed improvements were sustained for 24 months.

Conclusions:

  • A combination of quality improvement strategies can significantly decrease pRBCT in preterm infants (26-34 weeks gestation).
  • These interventions are effective and sustainable.
  • This approach offers a viable method for reducing transfusion-related risks in this vulnerable population.
Abstract

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
537
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
675
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K